Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dhananjay Chitale

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
American Journal of Translational Research|February 21, 2012
Epigenetic silencing of miR-34a in human prostate cancer cells and tumor tissue specimens can be reversed by BR-DIM treatmentDejuan Kong, Elisabeth Heath, Wei Chen, et al.
BMC Cancer|May 16, 2015
Autoantibodies in breast cancer sera are not epiphenomena and may participate in carcinogenesisFélix Fernández Madrid, Marie-Claire Maroun, Ofelia A Olivero, et al.
The Breast Journal|April 27, 2019
Distribution and Short-term Prognostic Value of the 21-gene recurrence score in African American compared to White American breast cancer patientsAli Amro, Yalei Chen, Renee Barry, et al.
BMC Medical Genomics|August 22, 2020
Breast and prostate cancers harbor common somatic copy number alterations that consistently differ by race and are associated with survivalYalei Chen, Sudha M Sadasivan, Ruicong She, et al.
Plos One|March 24, 2012
Loss of let-7 up-regulates EZH2 in prostate cancer consistent with the acquisition of cancer stem cell signatures that are attenuated by BR-DIMDejuan Kong, Elisabeth Heath, Wei Chen, et al.
Annals of Surgical Oncology|April 22, 2018
Utilization of the 21-Gene Recurrence Score in a Diverse Breast Cancer Patient Population: Development of a Clinicopathologic Model to Predict High-Risk Scores and Response to Neoadjuvant ChemotherapyKo Un Park, Yalei Chen, Dhananjay Chitale, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 16, 2023
Convolutional Neural Network Quantification of Gleason Pattern 4 and Association With Biochemical Recurrence in Intermediate-Grade Prostate TumorsYalei Chen, Ian M Loveless, Tiffany Nakai, et al.
Cancer Research|November 18, 2008
Genetic predictors of MEK dependence in non-small cell lung cancerChristine A Pratilas, Aphrothiti J Hanrahan, Ensar Halilovic, et al.
Cancer Research|July 18, 2008
Novel MEK1 mutation identified by mutational analysis of epidermal growth factor receptor signaling pathway genes in lung adenocarcinomaJenifer L Marks, Yixuan Gong, Dhananjay Chitale, et al.
Journal of Trace Elements in Medicine and Biology : Organ of the Society for Minerals and Trace Elements (GMS)|May 19, 2018
Association between cadmium and androgen receptor protein expression differs in prostate tumors of African American and European American menChristine M Neslund-Dudas, Russell B McBride, Ashoka Kandegedara, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
American Journal of Translational Research|February 21, 2012
Epigenetic silencing of miR-34a in human prostate cancer cells and tumor tissue specimens can be reversed by BR-DIM treatmentDejuan Kong, Elisabeth Heath, Wei Chen, et al.
BMC Cancer|May 16, 2015
Autoantibodies in breast cancer sera are not epiphenomena and may participate in carcinogenesisFélix Fernández Madrid, Marie-Claire Maroun, Ofelia A Olivero, et al.
The Breast Journal|April 27, 2019
Distribution and Short-term Prognostic Value of the 21-gene recurrence score in African American compared to White American breast cancer patientsAli Amro, Yalei Chen, Renee Barry, et al.
BMC Medical Genomics|August 22, 2020
Breast and prostate cancers harbor common somatic copy number alterations that consistently differ by race and are associated with survivalYalei Chen, Sudha M Sadasivan, Ruicong She, et al.
Plos One|March 24, 2012
Loss of let-7 up-regulates EZH2 in prostate cancer consistent with the acquisition of cancer stem cell signatures that are attenuated by BR-DIMDejuan Kong, Elisabeth Heath, Wei Chen, et al.
Annals of Surgical Oncology|April 22, 2018
Utilization of the 21-Gene Recurrence Score in a Diverse Breast Cancer Patient Population: Development of a Clinicopathologic Model to Predict High-Risk Scores and Response to Neoadjuvant ChemotherapyKo Un Park, Yalei Chen, Dhananjay Chitale, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 16, 2023
Convolutional Neural Network Quantification of Gleason Pattern 4 and Association With Biochemical Recurrence in Intermediate-Grade Prostate TumorsYalei Chen, Ian M Loveless, Tiffany Nakai, et al.
Cancer Research|November 18, 2008
Genetic predictors of MEK dependence in non-small cell lung cancerChristine A Pratilas, Aphrothiti J Hanrahan, Ensar Halilovic, et al.
Cancer Research|July 18, 2008
Novel MEK1 mutation identified by mutational analysis of epidermal growth factor receptor signaling pathway genes in lung adenocarcinomaJenifer L Marks, Yixuan Gong, Dhananjay Chitale, et al.
Journal of Trace Elements in Medicine and Biology : Organ of the Society for Minerals and Trace Elements (GMS)|May 19, 2018
Association between cadmium and androgen receptor protein expression differs in prostate tumors of African American and European American menChristine M Neslund-Dudas, Russell B McBride, Ashoka Kandegedara, et al.
Pageof 6